Cortés GAS, Franco RS

Language: Spanish
References: 7
Page: 64-67
PDF size: 67.67 Kb.

ABSTRACT

The experience obtained with the early use of the surfactant alpha dornase and the use of nasal continuous positive airway pressure, could be a good strategy for to avoid mechanical ventilation in premature infants below 1,500 kg of body weight, and also could be reduce the risk of developing bronchopulmonary dysplasia.

REFERENCES

1. Mulhausen MG. Uso actual de presión continua en la vía aérea (CPAP) en recién nacidos. Rev Ped Elec (en línea) 2004; 1(11): 40-44 (www.revistadepediatria.cl/vol.num.1/11.htm.

2. Alanís GS, López GV, Rodríguez BI, Ábrego MV. Uso de alfa dornasa en el manejo de atelectasias de difícil resolución en recién nacidos. Rev Mex Pediatr 2003; 70: 143-45.

3. Rojas MH, Lozano JM, Rojas MX, Laug HM, Bose CL, Rondón MA et al. Very early surfactant without mandatory ventilation in premature infants treated with early continuos positive airway pressure. Randomized, controlled trial. Pediatrics 2009; 123: 137-42.

4. Gitterman MK, Fusch C, Gitterman AR, Regazzoni BM, Moessinger AC. Early nasal continuous positive airway pressure treatment, reduces the need for intubation in very low birth weight infants. Eur J Pediatr 1997; 156: 384-8.

5. Arjan B, Peter G, Davis C, Omar FK, Dawson J, Colm PF et al. Spontaneous breathing patterns of very preterm infants treated with continuous positive airway pressure at birth. Pediatr Res 2008; 64: 281-5.

6. Thomson MA, Bradley AY, Winter BS, Avedoni L, Chang LY, Coalson J. Delayed extubation to nasal continuous positive airway pressure in the immature baboon model of bronchopulmonary dysplasia: Lung clinical and pathological findings. Pediatrics 2006; 118: 2038-48.

7. Thomson MA. Presión positiva continua de la vía aérea nasal temprana para minimizar la necesidad de intubación endotraqueal y ventilación. Neo Reviews 2005; 6: 1-8.